At a glance
ClinicalIndex Comparison Record- ✓Admitted to ICU and currently receiving vasoactive drugs
- ✓Age ≥18 years
- ✓Expected ICU stay of at least 24 hours after enrollment
- ✕Expected to die imminently per clinical judgment
- ✕Mobilization contraindicated by nature of existing injuries
- ✕Neuromuscular disease, acute brain injury, or spinal cord injury
- ✕Unable to speak English (patient or consultee)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Investigating the Safety of Mobilising Intensive Care Unit Patients Receiving Vasoactive Drugs: An Exploratory Observational Study
In Brief
An observational study evaluating Mobilization for Critical Illness. Completed, enrolled 100 participants across 1 site.
Detailed Summary
There is a need to know more about the safety of mobilizing intensive care unit (ICU) patients who are receiving vasoactive drugs that support the heart and blood pressure. But before this research can be done, several uncertainties need to be addressed. To answer these uncertainties, the investigators will ask ICU patients receiving vasoactive drugs to take part in a study in three main stages. Firstly ICU patients will be asked whether they would be happy to take part in a future research trial on the safety of mobilizing patients who are receiving vasoactive drugs. Secondly, data will be collected about the current mobilization on vasoactive drugs that occurs. Finally, the investigators will try to follow up these patients 60 days after they start the study, to carry out some questionnaires and a walking test with the patients. These tests may be used in future research to measure the effect of mobilizing patients on vasoactive drugs.
Study Details
Timeline
Interventions
Physical rehabilitation